Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YAP1 and PRDM14 converge to promote cell survival and tumorigenesis. | Dev Cell | 2022 | 34990589 | PubTator, text mining | PubMed |
| Metabolic Regulation of Macrophages by SIRT1 Determines Activation During Cholestatic Liver Disease in Mice. | Cell Mol Gastroenterol Hepatol | 2022 | 34952202 | PubTator, text mining | PubMed |
| Correction to: The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells. | Oncogene | 2022 | 34930998 | PubTator, text mining | PubMed |
| Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants. | Clin Immunol | 2022 | 34922003 | PubTator, text mining | PubMed |
| Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer. | Cancer Discov | 2022 | 34911733 | PubTator, text mining | PubMed |
| Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase. | Nat Chem Biol | 2022 | 34857958 | PubTator, text mining | PubMed |
| Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia. | Leukemia | 2022 | 34857894 | PubTator, text mining | PubMed |
| Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4-pRB Axis in Fibroblasts at the Invasive Tumor Edge. | Cancer Res | 2022 | 34853070 | PubTator, text mining | PubMed |
| N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth. | Br J Pharmacol | 2022 | 34791641 | PubTator, text mining | PubMed |
| Survey of water supply and assessment of groundwater quality in the suburban communes of Selembao and Kimbanseke, Kinshasa in Democratic Republic of the Congo. | Sustain Water Resour Manag | 2022 | 34790861 | PubTator, text mining | PubMed |
| Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity. | Mol Cancer Ther | 2022 | 34789562 | PubTator, text mining | PubMed |
| Validation of a rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of vistusertib. | J Pharm Biomed Anal | 2022 | 34735991 | PubTator, text mining | PubMed |
| AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia. | Haematologica | 2022 | 34732043 | PubTator, text mining | PubMed |
| Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia. | Leukemia | 2022 | 34711926 | PubTator, text mining | PubMed |
| Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagy. | J Hepatol | 2022 | 34710483 | PubTator, text mining | PubMed |
| Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex. | Cell Mol Neurobiol | 2022 | 34709498 | PubTator, text mining | PubMed |
| Alignment of single-cell trajectories by tuMap enables high-resolution quantitative comparison of cancer samples. | Cell Syst | 2022 | 34624253 | PubTator, text mining | PubMed |
| TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition. | Mod Pathol | 2022 | 34561551 | PubTator, text mining | PubMed |
| RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy. | Cancer Discov | 2022 | 34544753 | PubTator, text mining | PubMed |
| Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. | Mod Pathol | 2022 | 34538873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=26